VERISIAN
LIVE

Serial Number

99607738

Owner

Verisian Ltd

Attorney

Parna A. Mehrbani

Filing Date

Jan 21, 2026

Add to watchlist:

No watchlists yet
View on USPTO

VERISIAN Trademark

Serial Number: 99607738

VERISIAN is a trademark filed by Verisian Ltd on January 21, 2026. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Verisian Ltd (2 trademarks)

86–90 Paul Street, 3rd Floor
London, England EC2A 4NE , GB

Entity Type: 99

Trademark Details

Filing Date

January 21, 2026

Registration Date

Not Registered

Goods & Services

Medical analysis services relating to the treatment and validation of clinical trial data; Medical information services provided via digital platforms; Issuing and compilation of medical reports, namely providing clinical trial regulatory submission documentation to clinical trial sponsor companies; Monitoring of medical data for medical diagnosis and treatment; Providing pharmaceutical information namely providing information regarding clinical trial data analytics and regulatory submission requirements; Provision of medical data analysis services for diagnostic and treatment purposes; Medical data analysis and validation services to support regulatory submissions and approval; Preparation of medical reports based on biometric and clinical data namely, providing clinical trial regulatory submission documentation; medical advisory services relating to patient access to clinical innovations; Support services for public health authorities in evaluating medical data namely providing software for review of clinical trial data and analyses by regulatory authorities

Scientific and technological services relating to clinical research in the field of clinical trials; software development for medical clinical trial data analysis and validation; Scientific research and analysis services in the field of pharmaceuticals and biotechnology; Preparation of scientific reports; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific research for medical purposes; Provision of scientific information; Software development tools for clinical research namely, provision of temporary use of online non-downloadable software; Programming of software for importing and managing data; Data management in the nature of data mining and warehousing and analytics services for clinical trials; Software as a service (SaaS) featuring software incorporating artificial intelligence (AI) tools for data validation, data analytics, machine learning and artificial intelligence; Software as a service (SaaS) featuring software for clinical trial analysis; Software as a service (SaaS) featuring software for data validation and regulatory submission; Development of databases used in clinical research and data validation; Development, updating and maintenance of artificial intelligence (AI) software and database systems; Development of computer programmes for data processing; Pharmaceutical research and development services; Development of software data programs for use with clinical trial analysis; Technical data analysis in the field of clinical trials; Design and development of computer software for evaluation and calculation of data; Design and development of computer software for regulatory submissions; Data validation services in relation to clinical research in the field of clinical trials; Providing online non-downloadable computer software platforms for monitoring and reviewing clinical studies; technical and scientific research consultancy services in the field of clinical trial data standardisation and compliance; technical and scientific research consultancy services in the field of drug development and medical research; technical and scientific research consultancy services in the field of clinical research; Scientific validation and oversight for clinical research and trials in the field of clinical trials; Providing information relating to pharmaceutical drug development; Provision of technical and scientific research information relating to clinical studies and treatments; Consultancy in the field of pharmaceutical research

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 30, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jul 30, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jul 30, 2026 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 22, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 22, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 22, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 21, 2026 GNRN
NON-FINAL ACTION E-MAILED
May 21, 2026 GNRT
NON-FINAL ACTION WRITTEN
May 21, 2026 CNRT
ASSIGNED TO EXAMINER
May 19, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 11, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Jan 21, 2026 MAFR
NEW APPLICATION ENTERED
Jan 21, 2026 NWAP